Início › Doença Falciforme › Nova York
Ensaios clínicos de Doença Falciforme em Nova York
21 estudos para Doença Falciforme estão buscando participantes em locais em Nova York.
Cidades em Nova York
Texto oficial do estudo (Inglês)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens Hospital at Montefiore, The Bronx
RecrutandoFase 3
Idades de 12 a 100 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Mount Sinai Hospital, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
RecrutandoFase 3
Idades 2 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- NYC Health+Hospitals, Brooklyn
- Interfaith Medical Center, Brooklyn
- Cohen Children's Medical Ctr, Queens
- e mais 2
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Icahn School of Medicine at Mount Sinai, New York
- Jacobi Medical Center, The Bronx
RecrutandoFase 2/3
Idades 12 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- e mais 2
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Mount Sinai Medical Center, New York
- Jacobi Medical Center, The Bronx
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Jacobi Medical Center, The Bronx
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Richmond University Medical Center- Site Number : 8400038, Staten Island
- Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx
RecrutandoFase 3
Idades de 10 a 65 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- New York Medical College, Valhalla
RecrutandoFase 2
6 Months – 21 Years · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT02675959Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
RecrutandoFase 1/2
Idades de 12 a 50 · Todos os sexos · Atualizado em 2 de jul. de 2026 · NCT04819841131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
- Columbia University Irving Medical Center, New York
RecrutandoFase 1
Idades de 12 a 50 · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT07015684Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Roswell Park (MRD-HCT), Buffalo
- Columbia Presbytarian (NT-DMT), New York
- Cohen's Children Hospital (NT-DMT), Queens
- e mais 4
RecrutandoEstudo observacional
Idades de 3 a 20 · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT06941389A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
RecrutandoFase 2
Idades de 2 a 50 · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RecrutandoFase 3
Idades de 12 a 35 · Todos os sexos · Atualizado em 23 de mar. de 2026 · NCT05477563Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Columbia University, New York
RecrutandoFase 2
Idades de 2 a 25 · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT03587272A Long-term Follow-up Study in Patients Who Received BEAM-101
- Columbia University Irving Medical Center, New York
RecrutandoEstudo observacional
Idades de 14 a 37 · Todos os sexos · Atualizado em 28 de jan. de 2026 · NCT07373639Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Weil Cornell Medical College, New York
- University of Rochester Medical Center, Rochester
Recrutando
Idades de 16 a 30 · Todos os sexos · Atualizado em 7 de jan. de 2026 · NCT06374238Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
- Mount Sinai Hospital, New York
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2025 · NCT05519111AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
RecrutandoFase 2
1 Day – 30 Years · Todos os sexos · Atualizado em 8 de ago. de 2025 · NCT04099966Cannabidiol in Sickle Cell Disease
- Icahn School of Medicine at Mount Sinai, Manhattan
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de jun. de 2025 · NCT06930703Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.